GLS - Gelesis Holdings, In...

Historical Data of Gelesis Holdings, Inc.(GLS), Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat

photo-url-https://financialmodelingprep.com/image-stock/GLS.png

Gelesis Holdings, Inc.

GLS

NYSE

Inactive Equity

Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipeline with potential therapies for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Gelesis Holdings Inc. was incorporated in 2006 and is headquartered in Boston, Massachusetts.

0.159 USD

0 (0%)

Overview Profile Financial Statements Financial Ratios Chart Analysis News Corporate Actions DCF

Historical Prices

From:

To:

We are unable to load the chart at this time.

FMP

Home Terms of Service Privacy Policy Blog Contact Us

API

Documentation Pricing Formulas Market Indexes

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.